Basics Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application. IPO Date: December 1, 2013 Sector: Healthcare Industry: Medical Devices Market Cap: $1.43B Activated in VL: True Average Daily Range Avg Daily Range: $0.97 | 2.77% Avg Daily Range (30 D): $0.50 | 2.51% Avg Daily Range (90 D): $0.51 | 2.30% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): 1.29M Avg Daily Volume (90 D): 1.36M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 6,531 Avg Inst. Trade: $2.78M Avg Inst. Trade (30 D): $2.18M Avg Inst. Trade (90 D): $2.13M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.98M Avg Closing Trade (30 D): $3.93M Avg Closing Trade (90 D): $4.02M Avg Closing Volume: 97.53K         News Jan 24, 2025 @ 10:00 AM Infusion Devices Market to Reach US$ 23.08 Billion... Source: The Insight Partners Dec 24, 2024 @ 2:30 PM Insulin Pump Market Valuation to Jump to Reach US$... Source: Astute Analytica Sep 19, 2024 @ 10:49 PM Why Tandem Diabetes Care Stock Thrashed the Market... Source: Eric Volkman Jul 23, 2024 @ 5:31 PM [Latest] US Diabetes Devices Market Size/Share Wor... Source: Custom Market Insights Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.78 $-1.97 $.01 Diluted EPS $-2.78 $-1.97 $.01 Revenue $ 982.95M $ 234.42M $ 282.65M Gross Profit $ 513.31M $ 118.41M $ 157.46M Net Income / Loss $ -183.87M $ -130.56M $ .76M Operating Income / Loss $ -178.33M $ -120.88M $ -.58M Cost of Revenue $ 469.64M $ 116.02M $ 125.19M Net Cash Flow $ -5.41M $ -15.66M $ 20.2M PE Ratio     Splits Oct 10, 2017:   1:10